Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 3 de 3
Filtrer
Plus de filtres










Base de données
Gamme d'année
1.
Osteoporos Int ; 24(8): 2359-63, 2013 Aug.
Article de Anglais | MEDLINE | ID: mdl-23371326

RÉSUMÉ

Treatment of vitamin D deficiency with vitamin D is a common procedure when taking care of elderly patients, calcium supplementation being added only when calcium dietary intake is insufficient. Here, we report the case of a 58-year-old female who was referred to our unit because of suspicion of Paget's disease of the skull, based on elevated serum alkaline phosphatase and high skull methylene diphosphonate-technetium uptake. She had been prescribed cholecalciferol (100,000 IU/month) and calcium salts for the past 7 months after discovery of severe vitamin D deficiency by her primary care physician. No specific skull bone lesions were observed on both X-ray and computerized tomography. Serum calcium, phosphate and 25(OH) vitamin D levels were normal, while serum C-terminal cross-linked telopeptide, bone alkaline phosphatase and calcitriol were high and daily urinary calcium excretion was low. We found that she had not been compliant with the calcium prescription while vitamin D had been thoroughly taken. We suspected osteomalacia due to calcium deficiency. Both skull uptake and biological abnormalities normalised in few months after adding calcium supplementation to the vitamin D treatment, and spine bone mineral density increased by 9.5 % after 14 months of full treatment. The present case illustrates the necessity for adequate calcium intake during vitamin D repletion to normalise bone mineralisation and turnover and maintain the skeletal integrity.


Sujet(s)
Remodelage osseux/effets des médicaments et des substances chimiques , Calcium/déficit , Cholécalciférol/usage thérapeutique , Ostéomalacie/étiologie , Carence en vitamine D/traitement médicamenteux , Phosphatase alcaline/sang , Densité osseuse/effets des médicaments et des substances chimiques , Densité osseuse/physiologie , Remodelage osseux/physiologie , Calcium/sang , Calcium/usage thérapeutique , Compléments alimentaires , Femelle , Humains , Adhésion au traitement médicamenteux , Adulte d'âge moyen , Ostéomalacie/diagnostic , Ostéomalacie/physiopathologie , Carence en vitamine D/physiopathologie
3.
Presse Med ; 21(37): 1758-61, 1992 Nov 07.
Article de Français | MEDLINE | ID: mdl-1488421

RÉSUMÉ

A new case of Schnitzler's syndrome is reported in a 72-year old man hospitalized for severe deterioration of his general condition associated with recurrent ancient urticaria. Paraclinical examinations, which showed inflammatory syndrome, bone condensation and IgM monoclonal gammapathy, led to the diagnosis of Schnitzler's syndrome, first described in 1972. Twenty-two cases have now been published, characterized by vasculitic urticaria, osteosclerosis and IgM macroglobulinaemia. There is also severe inflammatory syndrome and the other immunological examinations are normal. Recent studies suggest the possibility of uncontrolled activity of interleukin-1 alpha. The condition is chronic and usually benign, but the fear of malignant transformation in the long term makes the therapeutic choice difficult.


Sujet(s)
Immunoglobuline M , Inflammation/complications , Ostéosclérose/complications , Urticaire/complications , Macroglobulinémie de Waldenström/complications , Sujet âgé , Biopsie , Humains , Mâle , Ostéosclérose/imagerie diagnostique , Radiographie , Scintigraphie , Syndrome , Urticaire/anatomopathologie , Vascularite/complications
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE